Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
56.76
-0.86 (-1.50%)
Streaming Delayed Price
Updated: 12:24 PM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
90
91
Next >
Looking to Buy Bristol Myers Squibb Stock on the Dip? Read This First.
↗
May 24, 2026
The numbers don't tell the full story with this big pharma stock.
Via
The Motley Fool
Topics
Intellectual Property
Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline
May 21, 2026
From
Bristol Myers Squibb
Via
Business Wire
The Most Undervalued Healthcare Stock in the S&P 500 Right Now
↗
May 21, 2026
The market appears to be short-sighted.
Via
The Motley Fool
Topics
Intellectual Property
Stocks
1 Profitable Stock to Keep an Eye On and 2 We Brush Off
May 21, 2026
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via
StockStory
Topics
Energy
Bristol Myers Squibb (NYSE:BMY) Q1 2026 Earnings Beat Driven by Growth Portfolio
↗
April 30, 2026
Via
Chartmill
Topics
Earnings
Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations
May 20, 2026
From
Bristol Myers Squibb
Via
Business Wire
3 High-Yielding Dividend Stocks Trading at Dirt Cheap Valuations
↗
May 18, 2026
These stocks are facing adversity, but with high yields and cheap valuations, investors may be compelled to take a chance on them.
Via
The Motley Fool
10 Years Later: 5 Winners in a Thinking World
↗
May 13, 2026
What happens when you actually do the thing most investors only talk about and hold stocks for a full decade?
Via
The Motley Fool
2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down
May 13, 2026
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...
Via
StockStory
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
May 12, 2026
From
Pacira BioSciences
Via
GlobeNewswire
Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q1 Earnings?
May 12, 2026
Bristol-Myers Squibb has had an impressive run over the past six months as its shares have beaten the S&P 500 by 5.7%. The stock now trades at $55.77, markin...
Via
StockStory
Topics
Stocks
Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors.
↗
May 11, 2026
This may be an excellent deal for those focused on the long game.
Via
The Motley Fool
Topics
Intellectual Property
Bristol Myers Squibb Touts Pipeline Gains as Shareholders Back Board at Annual Meeting
↗
May 10, 2026
Bristol Myers Squibb (NYSE:BMY) used its 2026 annual meeting of shareholders to highlight progress in its growth portfolio, pipeline development, balance sheet management and cost-saving initiatives,...
Via
MarketBeat
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
May 08, 2026
From
Bristol Myers Squibb
Via
Business Wire
Bristol-Myers Squibb’s Q1 Earnings Call: Our Top 5 Analyst Questions
May 07, 2026
Bristol-Myers Squibb’s first quarter results were notably shaped by ongoing momentum in its growth portfolio and steady execution across key marketed product...
Via
StockStory
Topics
Earnings
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026
May 06, 2026
From
Bristol Myers Squibb
Via
Business Wire
1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges
May 06, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged...
Via
StockStory
Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™
May 04, 2026
From
Bristol Myers Squibb
Via
Business Wire
BMY Q1 Deep Dive: Growth Portfolio, Pipeline Milestones, and Anticipated Late-Stage Readouts
May 01, 2026
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q1 CY2026, with sales up 2.6% year on year to $11.49 bill...
Via
StockStory
Why Bristol Myers Squibb Stock Rocked the Market Today
↗
April 30, 2026
It scored crushing beats on both revenue and profitability in its first quarter.
Via
The Motley Fool
Bristol Myers (BMY) Q1 2026 Earnings Transcript
↗
April 30, 2026
Bristol Myers (BMY) Q1 2026 Earnings Transcript
Via
The Motley Fool
Bristol-Myers Squibb (NYSE:BMY) Exceeds Q1 CY2026 Expectations
April 30, 2026
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q1 CY2026, with sales up 2.6% year on year to $11.49 bill...
Via
StockStory
Bristol Myers Squibb Reports First Quarter Financial Results for 2026
April 30, 2026
From
Bristol Myers Squibb
Via
Business Wire
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q1 Results Tomorrow
April 28, 2026
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting earnings this Thursday before market open. Here’s what investors should know. Bri...
Via
StockStory
3 Healthcare Stocks That Pay You While You Wait for the Growth
↗
April 27, 2026
It may not seem like it at first, but these dividends are safe.
Via
The Motley Fool
Topics
Intellectual Property
3 Biotech Stocks That Could Benefit from the Patent Cliff
↗
April 27, 2026
Via
MarketBeat
Topics
Intellectual Property
Is Bristol Myers Squibb the Best Bargain in Big Pharma?
↗
April 27, 2026
This pharma stock is cheap for a reason.
Via
The Motley Fool
Topics
Intellectual Property
Bristol Myers Squibb: Low Volatility Meets High Dividend Yield
↗
April 26, 2026
Volatility and dividend yield are important metrics for investors thinking about a long-term buy.
Via
The Motley Fool
Topics
Intellectual Property
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
↗
April 25, 2026
As you wait for stock prices to rebound, these three healthcare companies pay dividends with generous yields.
Via
The Motley Fool
Topics
Intellectual Property
World Trade
1 Unpopular Stock That Should Get More Attention and 2 We Question
April 22, 2026
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
90
91
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.